期刊文献+

非亲缘异基因骨髓移植病人肝静脉闭塞病的护理 被引量:2

非亲缘异基因骨髓移植病人肝静脉闭塞病的护理
下载PDF
导出
摘要 造血干细胞移植后并发肝静脉闭塞病 (VOD)是造血干细胞移植后与预处理有关的危及生命的严重并发症。根据骨髓移植及VOD的临床特征 ,阐述了异基因骨髓移植预处理护理、VOD预防的护理、VOD发生时的护理及心理护理等。
出处 《护士进修杂志》 北大核心 2002年第8期589-590,共2页 Journal of Nurses Training
关键词 非亲缘异基因骨髓移植 肝静脉闭塞病 护理 VOD 并发症 治疗 诊断 Non-consanguinity marrow transplantation Liver vein occlusion Nursing
  • 相关文献

参考文献3

二级参考文献2

  • 1陈虎,中华血液学杂志,1993年,14卷,66页
  • 2Mcl Attal,Blood,1992年,79卷,2834页

共引文献20

同被引文献18

  • 1李秋平,朱为国,尹晓娟,封志纯.肝素联合前列地尔脂质微球体和低分子右旋糖酐防治造血干细胞移植后肝静脉闭塞症[J].中华儿科杂志,2004,42(7):537-538. 被引量:5
  • 2Carreras E,Bertz H,Arcese W,et al.Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation:a prospective cohort study of the European group for blood and marrow transplantation[ J].Blood,1998,10(2):3599 -604.
  • 3Bearman S L.The syndrome of hepatic veno-occlusive disease after marrow transplantation[ J ].Blood,1995,85:3005 -20.
  • 4Lee JH,Choi SJ,Lee JH,et al.VOD Decreased incidence of hepatic veno-occlusive disease and fewer hemostatic derangements associated with intravenous Busulfan vs oral Busulfan in adults conditioned with Busulfan + cyclophosphamide for allogeneic bone marrow transplantation[ J ].Ann Hematol,2005,84(5):321-30.
  • 5Je-Hwan Lee,Kyoo-Hyung Lee,Jung-Hee Lee,et al.Plasminogen activator inhibitor-1 is an independent diagnostic marker as well as severity predictor of hepatic veno-occlusive disease after allogeneic bone marrow transplantation in adults conditioned with busulphan and cyclophosphamide[ J ].British Journal of Haematology,2002,118 (6):1087 -94.
  • 6Satori MT,Spiezia L,Cesaro S,et al.Role of fibrinolytic and clotting parameters in the diagnosis of liver veno-occlusive disease after hematopoietic stem cell transplantation in a pediatric population[ J ].Thromb Haemost,2005,93 (4):682-9.
  • 7Attal M,Huguer F,Robie H,et al.Prevention of hepatic Veno-occlusive desease after bone marrow transplantation by continuous infusion of low dose heparin[ J ].Blood,1992,79(9):2834.
  • 8Forrest DL,Thompson K,Dorcas VG.Low molecular weight heparin for the prevention of hepatic veno-occlusive disease (VOD) after hematopoietic stem cell transplantation:a prospective phase Ⅱ study[ J ].Bone Marrow Transplant,2003,31 (12):1143-9.
  • 9Inukai T,Sugita K,Goi K,et al.Prevention of hepatic veno-occlusive disease by a combination of heparin and prostaglandin E1 in children undergoing hematopoietic stem cell transplantation[ J ].Rinsho Ketsueki,2004,45 (4):297-303.
  • 10Bearman SI,Lee JL,Baron AE,et al.Treatment of hepatic venocclusive disease with recombinant human tissue plasminogen activator and heparin in 42 marrow transplant atients[ J ].Blood,1997,89 (5):1501-6.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部